Medical Information Archives - Techsol Life Sciences

Case Study Neurology (Anxiety)

Vinoth — Tue, 10 Jun 2025 10:06:04 +0000

Case Study Neurology (Anxiety)

 Geography: N/A
 Type Service: N/A

Background/Client Requirement:

A prominent Nano therapeutics company, renowned for its creation in innovative products in specific therapeutic areas such as Pain management, Supportive care, CNS Disorders, Immunomodulators collaborated with Techsol Lifesciences to conduct clinical trial for their Cannabidiol oral solution ensuring compliance with principles of good clinical practice in accordance with the health authority regulations.

Project Objectives:

The aim was to conduct a multicenter Phase-III clinical trial across India to enroll patients with mild to moderate anxiety disorders and evaluate the Efficacy, Safety and Pharmacokinetics of Cannabidiol oral solution compared to a matching Placebo for the treatment of mild to moderate anxiety disorders.

The study objectives included:

Primary Objectives: To assess the changes in the Generalized Anxiety Disorder Scale (GAD-7) and Hamilton Rating Scale for Anxiety (HAM-A) scores at the end of treatment (Visit 9, Week 11) compared to baseline for evaluating mild to moderate anxiety disorders.
Secondary Objectives: To evaluate changes in scores for the Clinical Global Impression-Improvement (CGI-I), Clinical Global Impression-Severity (CGI-S), Patient Health Questionnaire-9 (PHQ-9), and Pittsburgh Sleep Quality Index (PSQI) at the end of treatment compared to baseline.

Challenges:

EDC vendor on-boarding process
Study database design: Complex study design requirements, combined with tight timelines for study go-live made database design critical.
Data Quality: Ensuring the quality and reliability of the data was crucial. The high volume of data increased risk of low-quality or irrelevant information, which impacts decision-making.
High Volume of Data: Sorting through a large volume of data was overwhelming, leading to system performance issues and difficulty in identifying relevant insights for day-to-day clinical operations.

Techsol Solution/Approach:

As per the client’s requirement, we have identified and selected a vendor capable of providing EDC solutions within very short timeframe, meeting sponsor’s stringent timelines in conducting clinical study.
To ensure the highest quality and regulatory compliance, we validated the EDC solution in accordance with 21 CFR Part 11 guidelines for computer system validation.
Our data management team design the CRF in accordance with the study protocol and obtained client approval. Following approval, our data management team worked closely and rigorously with the vendor’s database team to design and build study in EDC solution, adhering to industry best standards (CDISC).
Techsol provided various artifacts like eCRF data entry guidelines, role-based training, and documentation for EDC applications users, ensuring accurate data capture the study sites.
Our CDM team has initiated various activities related to data cleaning and thrived hard to achieve quality. This included close collaboration with site personnel to ensure accurate data entry as per source documentation through regular follow-ups. Additional training and guidelines were provided to site users as needed.
In line with our SOP’s, we ensured timely responses for the discrepancies raised by data management team. To facilitate this, we conducted weekly meetings with all key business stakeholders to address any hurdles in achieving our target.
A dedicated QC team, including designated medical monitor, lead data management personal to perform 100% data review for critical and non-critical study data points.
CDM team worked closely with vendor in identifying the system bottlenecks and optimized the data for better performance
Developed complex and custom dashboards and reports to support the Clinical data managers, Investigators, site coordinators, and research associates, enabling more efficient and accurate day-to-day activities.

Project Achievements:

Techsol has consistently delivered high-quality data and managed end-to-end processes by involving the right stakeholders to achieve key milestones.

Comprehensive Documentation: The team successfully designed CRFs, aCRF’s, reports, metadata, while providing valuable inputs to the DB team to ensure accurate clinical data recording. This included detailed documentation of the methodology, data sources, analysis, and conclusions drawn.
Data cleaning: Unlike the traditional approach where CDM reviews data only after source data verification by site monitors, Techsol adopted a proactive approach by initiating data cleaning as soon as data is entered by the site. This supported risk-based monitoring, allowing monitors to address CDM issues prior to their next site visit. This approach resulted in more efficient data monitoring and streamlined data cleaning. As a result, Techsol’s biostatisticians were able to confidently transfer semi-clean monthly SDTM datasets. Additionally, CDM provided transparent updates to the Sponsor’s clinical operations team through weekly and ad-hoc reports to ensure that resources were focused where most needed.
Data Quality: Prior to final QA assessment, data underwent rigorous review specialist QC team including critical and non–critical data points essential for the conduct of the study. This meticulous review process ensured that data points were missed during review, enabling Techsol to achieve 100% data quality.

The Outcome:

Techsol’s continued support in clinical data evaluation, coupled with industry best practices, has been instrumental in the partnership’s success. This achievement is attributed to the collaboration between experienced resources and the client’s QA team. By leveraging Techsol’s expertise, multiple documents are delivered swiftly, meeting expedited timelines without compromising quality. This streamlined approach ensures compliance with data cleaning standards while maximizing efficiency.

Talk to an Expert

how can we help you?

[contact-form-7]

The post Case Study Neurology (Anxiety) appeared first on Techsol Life Sciences.

Case Study Endocrinology (Diabetes mellitus)

Vinoth — Tue, 10 Jun 2025 09:43:42 +0000

Case Study Endocrinology (Diabetes mellitus)

 Geography: N/A
 Type Service: N/A

Background/Client Requirement:

Our client a leading provider of in-vitro diagnostics and a global supplier of transformative, innovative solutions across major therapeutic areas. Committed to develop new medicines and diagnostics that make life better. Client collaborated with Techsol Life Sciences to conduct a clinical trial focused on Diabetes Empowerment of Subjects with Type 2 Diabetes Mellitus.

Project Objectives:

The scope of the study is to evaluate diabetes empowerment, health literacy, diabetes treatment satisfaction, and user experience. The study population assess the outcome characteristics for 8-weeks without the blood glucose monitoring devices followed by a 12-week observational phase using the blood glucose monitoring devices, active test strips and a lancing device and lancets. Diabetes empowerment is measured by the Diabetes Empowerment Scale-Short Form (DES-SF) questionnaire.

Challenges:

Converting Fast Healthcare Interoperability Resources (FHIR) data for Clinical Data Interchange Standards Collaboration (CDISC) standards can indeed present several challenges, primarily due to differences in structure, Study of meaning, and intended use between the two standards.

Inconsistent Data Structure: The clinical data management finds complexity in transforming FHIR data provided by the sponsor, often in an incorrect format, into the required CDISC standard format.
Missing or Incomplete Data: Sponsors provide FHIR data to Clinical Data Management (CDM), which include missing or incomplete data, complicating the conversion process.
Terminologies: FHIR resources can have different terminologies from CDISC, making mapping complex when dealing with custom/local codes, ensuring collaboration equivalence and accuracy.
Data Cleaning: Converting data from FHIR to CDISC standards is work-intensive, involving extensive data cleaning, organization, error correction, and terminology alignment. Manual execution is time-consuming and error-prone.
Tools and Resources: Ensuring the availability of tools with the necessary features and capabilities to efficiently and accurately convert FHIR data to CDISC standards is a significant challenge, especially given limited resources.
Training and Education: This is first of its kind requirement, with no readily available training materials and resources available to guide internal team to develop/validate the tools and the data. Explaining data in JSON format can be challenging. Healthcare professionals, IT teams, and developers should be briefed on FHIR and CDISC standards, data models, and terminology, and develop skills and manage data exchange effectively.
Standardization Plan: A standardization plan need to be developed to transform FHIR data into a uniform format, ensuring consistent use of CDISC data elements, terminology, and coding schemes across the dataset.

Techsol Solution/Approach:

To convert FHIR data to CDISC standards successfully, a comprehensive approach is needed that tackles technical and organizational aspects.
Clinical Data Management develops transformation guidelines for convert FHIR data into the required standard format with version control, ensuring the integrity and accuracy of the transformed data. The process follows standardized formats with CDISC based on the mapping document, providing a robust verification process.
Techsol clinical data management approached by implementing with data validation checks to identify inconsistencies, missing values or discrepancies within the FHIR data. This can involve checks for data integrity, completeness, and adherence to standards.
Terminology Mapping: Map the terminology used in the FHIR standard to CDISC standard data vocabularies such as ICD-10 (International Classification of Diseases), develop comprehensive terminology mappings to ensure consistency and interoperability across datasets.
Tools and Resources: Techsol’s Clinical Data Management team have developed In-house tool to export the data output with CDISC standards in human readable format and it is easy to analysis.
Training and Education: We have nominated qualified resource to self-learn the FHIR data standards and developed training materials and documents for software development and also provided trainings, guidance, including manuals and power point presentations for internal team and QC/QA teams.
Data Cleaning: Implemented robust data quality checks at various stages of the data management process. This includes both API’s checks using software tools and manual checks by experienced data management team and medical experts.
Team collaboration: Regular meetings and discussions helped to identify challenges early on and find effective solutions collectively.
Standardization Plan: The implementation of In-house software tools, adhering to industry-standard formats and protocols, has been instrumental in maintaining data consistency and promoting interoperability.

Project Achievements:

The clinical data management and QC teams successfully met their deadlines, earning positive feedback from the sponsor. Open communication within the team, created a collaborative atmosphere that facilitated the seamless exchange of information, which is an essential factor for the success of the study. Stakeholders and investigators commended the teams performance, acknowledging its vital role in carrying out the study with exceptional efficiency and effectiveness.

The Outcome:

Techsol’s continued support in clinical data evaluation, combined with the application of industry best practices, ensured that the study outcomes align with the client’s strategic goals and objectives, solidifying its position as a leader in diabetes care innovation and digital health solutions. The outcomes emphasize key aspects such as data quality, timelines, goal attainment, and complication management. Each of these factors ensured the validity and reliability of study findings and ultimately advancing medical knowledge and improving patient care.

Talk to an Expert

how can we help you?

[contact-form-7]

The post Case Study Endocrinology (Diabetes mellitus) appeared first on Techsol Life Sciences.

Case Study on anxiety disorders

Vinoth — Tue, 10 Jun 2025 08:13:57 +0000

Case Study on anxiety disorders

Geography: N/A
Type Service: N/A

Background/Client Requirement:

A global pharmaceutical innovation company with a strong history of successful product commercialization and alliance partnerships, outsourced Techsol Lifesciences to conduct comparative study to evaluate the Efficacy, Safety and Pharmacokinetics of two drugs for the treatment of mild to moderate anxiety disorders.

Project Objectives:

The aim was to assess the Generalized Anxiety Disorder Scale (GAD-7) scores at the end of the treatment Visit 9 (Week 11) compared to baseline for assessing mild to moderate anxiety disorders. The change in Clinical Global Impression-Improvement (CGI-I), Clinical Global Impression – Severity (CGI-S), Patient´s Health Questionnaire-9 (PHQ-9) and Pittsburgh Sleep Quality Index (PSQI) scores at end of the treatment visit 9 (Week 11) were compared to baseline.

Challenges:

Complexity in SAP Design: Crafting the Statistical Analysis Plan (SAP) to accurately capture changes in GAD-7 scores was challenging. The SAP needed to be meticulously structured to align with the study objectives, including baseline comparisons and endpoint analyses, while accounting for diverse patient demographics and clinical variables.
Mock Shell Accuracy and Alignment: Developing mock shells that accurately represented the expected output for scale scores data was another critical hurdle. These mock shells needed to account for the various score distributions and outcomes, ensuring consistency with the SAP requirements. Discrepancies between the SAP and the mock shells occasionally led to misalignment of the reporting structure, which necessitates additional time for revisions and validation.
Data Variability and Interpretability: Mock shells also had to capture the range of possible data variability and ensure clarity in interpreting scores for mild to moderate anxiety over time. Given the variability in patient responses to treatment, establishing consistent reporting across study visits was essential to prevent misinterpretation or loss of crucial data trends.

Techsol Solution/Approach:

Techsol’s collaborative approach with statisticians, clinicians, and data managers ensures that SAP effectively captures primary and secondary endpoints, while meeting both regulatory and clinical requirements.
Creating mock shells in stages, incorporating regular feedback loops from data managers and analysts. This iterative process ensured alignment and accurately reflected the SAP specifications. Version-controlled templates allow easier tracking of changes and facilitate faster resolution of misalignments.
A strong emphasis was placed on ensuring consistency between the SAP and mock shells throughout the project.
Techsol developed a library of standardized mock shell templates tailored to common anxiety disorder measures, such as GAD-7. These templates include pre-set layouts for reporting scores, baseline comparisons, and patient demographics, reducing setup time and ensuring uniformity across analyses.
Weekly review meetings were conducted to address SAP and mock shell issues promptly. This enabled the team to identify and resolve misalignments swiftly, fostering effective communication and minimizing delays.

Project Achievements:

The study achieved significant milestones in assessing the effectiveness of the GAD-7 for tracking treatment progress in mild to moderate anxiety disorders.
A well-structured SAP was created and implemented. The SAP incorporated methods to account for various demographic and clinical variables, improving the robustness of the analysis.
Techsol team developed detailed mock shells that accurately reflected the SAP’s data output requirements, ensuring clarity and consistency in data reporting.
Through the use of automated validation tools, data normalization techniques, and error-checking software, the project achieved high standards of data quality. These measures minimized variability and ensured accurate reflection of changes in anxiety symptoms, providing reliable results.
The study provided clinicians with valuable insights into GAD-7 score changes, demonstrating the scale’s utility in assessing treatment outcomes. Data visualizations and standardized score thresholds facilitated easier interpretation, supporting clinical decision-making.

The Outcome:

This project successfully validated the primary scales as reliable tools for monitoring treatment progress in patients with mild to moderate anxiety disorders, showcasing the effectiveness of scales in monitoring symptoms changes from baseline through Visit 9 (Week 11). Specifically, the GAD-7 scale effectively captured symptoms change over time, with significant reduction in anxiety levels observed by the study’s endpoint.

A sensitivity analysis was conducted to evaluate the stability of the findings under various analytical assumptions. This analysis confirmed that the outcomes remained consistent across different scenarios.

Talk to an Expert

how can we help you?

[contact-form-7]

The post Case Study on anxiety disorders appeared first on Techsol Life Sciences.

Case Study on Meta-Analysis of Curcuma longa

Vinoth — Tue, 10 Jun 2025 07:43:39 +0000

Case Study on Meta-Analysis of Curcuma longa

 Geography: N/A
 Type Service: N/A

Background/Client Requirement:

Our client is a prominent pharmaceutical company renowned for its innovation in drug delivery systems and formulation development, focuses on enhancing therapeutic outcomes through advanced, technology-driven pharmaceutical products. The client specializes in the research, development, and commercialization of diverse healthcare solutions, particularly in novel drug delivery technologies. Its portfolio includes oral, injectable, and transdermal solutions designed to enhance patient compliance and provide more effective treatment options. The client has outsourced Techsol Lifesciences to conduct a meta-analysis on the safety and efficacy of turmeric (Curcuma longa) extract and curcumin supplements for musculoskeletal health.

Project Objectives:

The objective was to perform a systematic review and meta-analysis to evaluate the effective dose, safety, and efficacy of turmeric extract and curcumin supplements in promoting musculoskeletal health. This meta-analysis presents a comprehensive assessment of results and compares the effective doses of curcumin supplements for their impact on musculoskeletal health.

Challenges:

Conducting a meta-analysis presents several challenges, many of which stem from variations and limitations in the primary studies being analyzed.

Key challenges include:

Data Availability and Quality: Accessing high-quality, consistent data across studies can be challenging. Some studies may lack comprehensive data, use varying measurement techniques, or provide incomplete reporting.
Study Heterogeneity: Differences in study design, participant characteristics, and interventions can lead to heterogeneity, complicating pooled analysis
Publication Bias: Positive results are more likely to be published, leading to potential bias that can skew the meta-analysis.
Time-Consuming Process: The process requires extensive literature searches, meticulous data extraction, and rigorous quality assessment, making it labor-intensive and time-consuming.
Effect size: Inconsistent reporting of effect sizes hinder accurate comparisons across studies and estimation of an overall effect size.
Multiple outcome: Including multiple outcomes from the same study risks over-representation, while excluding the risks may result in omitting valuable insights.
Variability: High variability in study outcomes can pose challenges in assessing the reliability or generalizability of the findings.

Techsol Solution/Approach:

Our approach starts with strict implementation of inclusion criteria to ensure that only high-quality studies are included. Collaborate with study authors or utilize databases that ensure high reporting standards. Consider using imputation methods to address missing data points when necessary.
Conducting subgroup analyses or meta-regression to account for variability across studies. Alternatively, a random-effects model can help accommodate heterogeneity, though this should be used with caution.
Use statistical tools like funnel plots or Egger’s test to detect publication bias. Including unpublished studies or registered clinical trials can also help minimize this bias.
Train team members on best practices for systematic literature review and data extraction. Consider assigning specialized roles (e.g., one team for data extraction, another for quality assessment) to build expertise and further streamline each phase.
Applying multivariate meta-analysis techniques in R and NCSS for reporting multiple outcomes. These methods account for correlations among outcomes while selecting a primary outcome to avoid redundancy and over-representation of individual studies.
Interpret results with caution, particularly in the presence of high variability or potential biases. Employing NCSS and R tools to visualize data distributions and highlight variability. This ensures transparent reporting of study limitations and informs recommendations for future research.

Project Achievements:

Our robust approach to data collection, quality control, and analysis, this project achieved a high-quality meta-analysis on the safety and efficacy of turmeric (Curcuma longa) extract and curcumin supplements for musculoskeletal health.

Key achievements included:

High-Quality Data Selection: Strict inclusion criteria and collaboration ensured selection of high-quality studies. This improved data reliability and validity in the final analysis.
Effective Management of Study Heterogeneity: By applying subgroup analyses and a random-effects models, the approach effectively addressed variations across studies, leading to more nuanced understanding of turmeric’s effects on diverse patient groups.
Minimized Publication Bias: Utilization of funnel plots, Egger’s test, and inclusion of unpublished studies helped detect and reduce publication bias, ensuring a balanced and accurate meta-analysis.
Advanced Outcome Analysis: Adoption of multivariate meta-analysis techniques in R and NCSS enabled handling of correlated outcomes, preventing redundancy and ensuring a holistic representation of study findings.
Clear and Comprehensive Interpretation: Sensitivity analyses and data visualization visualization using NCSS and R tools facilitated transparent interpretation of variability and limitations, empowering stakeholders with actionable insights.

These achievements highlighted Techsol’s commitment to delivering reliable, efficient, and actionable meta-analyses, advancing the rigor and credibility of research synthesis processes, enabling more robust and actionable insights into turmeric and curcumin supplements for musculoskeletal health.

The Outcome:

The meta-analysis results indicate that turmeric extract and curcumin supplements can serve as effective adjuvants for the management of musculoskeletal health, with a low incidence of adverse events.
The studies included utilized diverse doses and treatment durations. Statistical evaluation revealed that water-dispersible turmeric extract at a low dose of 250 mg/day was found to be more effective than other curcumin products.
Further evaluation through future clinical trials is necessary to establish the appropriate effective dose of curcumin supplements for the overall maintenance of musculoskeletal health.

Talk to an Expert

how can we help you?

[contact-form-7]

The post Case Study on Meta-Analysis of Curcuma longa appeared first on Techsol Life Sciences.

Case Study on State of the Art (SoTA) for Refractive Surgery & Keratoplasty

Vinoth — Tue, 27 May 2025 08:18:28 +0000

Case Study on State of the Art (SoTA) for Refractive Surgery & Keratoplasty

Geography: Global
Type Service: Medical Writing

Sponsor:

The manufacturer, a leading provider of ophthalmic surgical instruments, faced the challenge of consolidating multiple reusable instruments and devices under one state-of-the-art report to meet the stringent requirements set by the EU MDR 2017/745 regulations. Facing a shortage of available data, the manufacturer sought a comprehensive solution to tackle the challenge and ensure compliance.

Techsol Approach:

Holistic Data Collection and Analysis: The team implemented a robust data collection system to gather detailed information on each reusable instrument and device. This involved collaborating with various departments to ensure all relevant data was captured.
Comprehensive Reporting: Extensive data analysis has been collected, systematically analyzed, and consolidated into a single cohesive report designed to meet the high standards of accuracy and detail required by the EU MDR regulations.
Regulatory Alignment: Working closely with regulatory experts ensured that the report meets all specific standards and guidelines, with regular reviews and updates conducted to align the report with evolving regulatory requirements.

Challenges:

The Challenges was twofold

Data Consolidation: Covering a wide range of reusable instruments and devices in one comprehensive report. This required a holistic approach to gather, analyze, and present all necessary information accurately.
Regulatory Compliance: Complying with the EU MDR 2017/745 regulations added another layer of complexity. The state-of-the-art report needed to adhere to specific standards and guidelines set by regulatory authorities, ensuring that all data was presented in a compliant manner.

Solutions:

Techsol’s expertise team generated a State-of-the-Art report and carefully documented the state-of-the-art technologies and advancements in refractive surgery.
Our team meticulously reviewed the instruments/devices, and came up with a comprehensive solution, addressed data shortage, and ensured full compliance with EU MDR 2017/745 regulations.
Our comprehensive analysis encompassed areas such as efficiency, safety, effectiveness, and usability, providing Manufacturer with a detailed overview of the current landscape.
Benefits with Techsol: Partnering with us ensured regulatory compliance, streamlined documentation, facilitated comprehensive analysis with advanced technologies, and gained confidence in our analysis.

Project Outcomes:

Our collaboration resulted in a successful outcome, highlighting the importance of thorough data analysis and adherence to regulatory standards in the medical device industry. Manufacturer was able to demonstrate their commitment to excellence and compliance. We take pride in supporting the Manufacturer on their path to delivering innovative and dependable solutions for ophthalmic surgery.

If you would like to learn more about our services or discuss how we can assist your business, please feel free to reach out to us at info@techsollifesciences.com.

We look forward to helping you achieve your goals.

Talk to an Expert

how can we help you?

[contact-form-7]

The post Case Study on State of the Art (SoTA) for Refractive Surgery & Keratoplasty appeared first on Techsol Life Sciences.

Achieving Milestones for a Systematic Review & Meta-analysis Manuscript

Vinoth — Wed, 30 Apr 2025 09:22:56 +0000

Achievement in the Preparation of manuscript for a Systematic Review and Meta-Analysis

 Geography: Global
 Type Service: Authoring Manuscript

Overview:

In the highly competitive pharmaceutical industry landscape, sharing of research findings through scientific manuscripts is vital for advancing medical knowledge and promoting therapeutic innovations. Techsol, is a leading service provider of specialized scientific solutions, and plays a crucial role in supporting pharmaceutical companies with crafting high quality manuscripts. This case study highlights how Techsol expertise in manuscript development ensures the production of exceptional publications, enhancing the reputation and credibility of the client.

Background/Client Requirement:

Drafting a systematic review and meta-analysis manuscript is a rigorous task that requires detailed planning, thorough literature research and clear, structured writing. The sponsor, primarily a pharmaceutical manufacturing company, approached Techsol life sciences to craft a systematic review and meta-analysis manuscript, leveraging Techsol’s expertise in medical writing services.

Project Aim:

The aim of the project was to support the sponsor in preparing a systematic review and meta-analysis manuscript that adhered to industry standards.
Techsol Approach:

Techsol’s approach to this project involved:

In-depth Planning: We began by understanding the sponsor’s objectives and key areas of interest for the systematic review and meta-analysis.
Comprehensive Literature Search: Utilizing advanced databases and resources, we conducted an exhaustive search for relevant studies, ensuring the inclusion of high-quality research articles.
Data Extraction & Analysis: The team meticulously extracted and analyzed data, ensuring that statistical methods were aligned with the latest guidelines and best practices in meta-analysis.
Structured Writing: With clear and concise writing, we ensured that the manuscript adhered to established guidelines, including PRISMA, for systematic reviews and meta-analyses.
Review & Refinement: Multiple rounds of internal and client reviews ensures highest quality standards.

Challenges:

Challenges encountered throughout the manuscript drafting include:

Data Inconsistencies: One primary hurdle involved was the exhaustive task of scouring extensive databases to identify pertinent studies, necessitating careful search strategies aligned with specific inclusion criteria.
Complex Statistical Methods: The meta-analysis demanded the application of advanced statistical techniques to synthesize results across multiple studies. This complexity introduced challenges in maintaining both accuracy and clarity in the analysis, requiring meticulous attention to detail.
Time Constraints: A pressing deadline further compounded the difficulties, creating pressure to complete the project within a short timeframe. A pressing deadline further compounded the difficulties, creating pressure to complete the project within a short timeframe.
Ethical Concerns: Moreover, dealing with ethical concerns such as plagiarism and data falsification posed formidable obstacles, as these actions could compromise the manuscript’s integrity and erode trust in the research findings.

To address these challenges, Techsol’s expertise in medical writing, data management, statistical analysis, and project coordination played a crucial role in delivering a high-quality, publication-ready document within the stipulated timeframe and with accurate output for the sponsor.

Solutions:

Effective Approach: A comprehensive strategy ensured clarity, thoroughness, and compliance with standard guidelines such as PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis).
AI-Driven Tool: Our exclusive AI-driven literature screening tool “COMPIER” played a vital role in extracting the accurate articles.
Literature Search: Our team conducted a thorough literature search using advanced search techniques and multiple databases (PubMed, Google Scholar, and Cochrane Library).
Manual Bibliography Checks: Our Medical writers even manually checked the bibliographies of the identified articles, including relevant systematic reviews and meta-analyses, to identify additional eligible studies.
Meticulous Project Planning: Planned the project timeline meticulously, set realistic deadlines, and prioritized tasks effectively.
Expert Statistical Support: The team incorporated advanced statistical tools and worked closely with biostatisticians to ensure that complex analyses were carried out correctly and presented clearly.
Streamlined Project Management: Techsol leveraged its streamlined project management processes, working in parallel on different sections of the manuscript to meet the deadline without compromising quality.
Regular Progress Meetings: Regular progress meetings helped to keep the project on track and we also used plagiarism detection software.
Multi-Layered Review Process: Performed a multi-layered review process (Peer review, Senior Medical writer review, QC review) to uphold scientific standards, which is crucial for publishing.

Project Achievements:

Timely Completion: Successfully drafted and delivered the manuscript within the stipulated timeline, meeting the sponsor’s urgent deadline.
High-Quality Manuscript: Delivered a well-structured, scientifically sound manuscript, adhering to PRISMA guidelines and ensuring it was ready for submission to high-impact journals

The Outcome:
The extensive systematic reviews and meta-analyses carried out by the medical writers had a notable influence.

Successful Manuscript Submission: The manuscript was successfully submitted to a high-impact journal, significantly enhancing the sponsor’s visibility in the scientific community.
Enhanced Client Reputation: The project contributed to the sponsor’s reputation as a leader in the pharmaceutical industry, particularly in the field of systematic reviews and meta-analyses.
Client Satisfaction: The sponsor expressed high satisfaction with Techsol’s medical writing ability to meet deadlines, maintain scientific rigor, and delivering a high-quality manuscript that addressed all of their requirements.

Call to Action

Are you looking to enhance your pharmaceutical research publication efforts?
Contact Techsol to discuss how we can support your projects with expert scientific and medical writing services.

Talk to an Expert

how can we help you?

[contact-form-7]

The post Achieving Milestones for a Systematic Review & Meta-analysis Manuscript appeared first on Techsol Life Sciences.